Position in AZN
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$3,758,683,247
New position
Shares Held
19,058,327
first reported quarter
Ownership
1.23%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 40.0759730903977.ToString("F0")%
Shared 0.ToString("F0")%
None 59.924026909602304.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $38,990,456,692 across 16 Drug Manufacturers - General names. AZN ranks #4 (9.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,125,832 | $10,233,206,495 | |
| 2 | JNJ |
Johnson & Johnson
|
25,516,697 | $6,237,301,411 | |
| 3 | ABBV |
AbbVie Inc.
|
23,936,943 | $5,206,045,728 | |
| 4 | AZN |
Astrazeneca PLC
This page
|
19,058,327 | $3,758,683,247 | |
| 5 | MRK |
Merck & Co., Inc.
|
30,774,221 | $3,701,831,041 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
19,978,936 | $2,784,464,307 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
32,586,981 | $1,976,400,394 | |
| 8 | AMGN |
Amgen Inc
|
5,121,028 | $1,801,833,698 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,758,683,247 | 19,058,327 | Shares | Defined | 2026-05-18 | |
| No filing history on record for this holder in this stock. | ||||||